🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase I trial to study the effectiveness of radiolabeled monoclonal antibod...
Status
Completed
Location
University of Alabama Comprehensive Cancer Center
Start Date
1996-03
Trial ID
NCT00002734
The objective of this phase I/II therapeutic human immunodeficiency virus (...
Status
Completed
Location
407 Doctors
Start Date
2002-09
Trial ID
NCT00332930
In face of the increased rates of tuberculosis in residents of long term ca...
Status
Completed
Location
Staten Island University Hospital
Start Date
2007-10
Trial ID
NCT00756808
The primary endpoint was the induction of T-regulatory cells under s specif...
Status
Completed
Location
Johann Wolfgang Goethe-university
Start Date
2011-10
Trial ID
NCT01830673
The purpose of this study was to evaluate the efficacy of IFN- Y combined w...
Status
Unknown
Location
Affiliated Hospital of Jiangnan University
Start Date
2022-12-20
Trial ID
NCT05268172
Treatments Being Tested
The purpose of this study is to assess whether the addition of the immune c...
Status
Recruiting
Location
Uniklinik RWTH Aachen, Department of Internal Medicine
Start Date
2023-01-10
Trial ID
NCT06019130
The human body knows a biphasic immunological reaction to sepsis. First, th...
Status
Completed
Location
Radboud University Nijmegen Medical Centre
Start Date
2011-05
Trial ID
NCT01374711
Treatments Being Tested
Study based in Southern Ethiopia Purpose - to explore if children in contac...
Status
Unknown
Location
Bushullo Major Health Centre
Start Date
2007-05
Trial ID
NCT00456469
Icaritin is a drug that has been approved by the National Medical Products ...
Status
Unknown
Location
Multiple Locations
Start Date
2024-03-01
Trial ID
NCT06285149
Treatments Being Tested
RATIONALE: Antifungals such as voriconazole may be effective in controlling...
Status
Completed
Location
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Start Date
2003-08
Trial ID
NCT00059878
Treatments Being Tested